The association between the history of supplement use (vitamin or mineral) and COVID-19 disease in the persian cohort population
- 作者: Ghorat F.1, Ganj Bakhsh A.1, Ataee R.1, Borghabani R.1, Jalambadani Z.1
-
隶属关系:
- Sabzevar University of Medical Sciences
- 期: 卷 14, 编号 2 (2024)
- 页面: 299-305
- 栏目: ORIGINAL ARTICLES
- URL: https://journals.rcsi.science/2220-7619/article/view/262370
- DOI: https://doi.org/10.15789/2220-7619-TAB-17593
- ID: 262370
如何引用文章
全文:
详细
The aim of the study was to examine the association between vitamin and mineral supplement consumption and the possibility of contracting COVID-19 disease in the Persian cohort population in 2020. This retrospective cohort study was conducted on 4241 people who were registered in the Cohort Registration System. A logistic regression was performed to ascertain the multivariate association between demographic, health variables, and supplement use and the likelihood that participants were infected with COVID-19. The software used was IBM SPSS 24.0, and a significance level of 0.05 was considered. Analyze the quantitative variables, if the variable was normal, the independent t-test was used, and if the variable was not normal, the Mann–Whitney test was used. To compare the distribution of qualitative variables in the groups, a chi-square test or, if necessary, a Fisher’s exact test was used. The number of participants in this cohort study was 4241. The average age of the participants in the study was 49.22±8.77. The OR value of age variable 0.989 (95% CI: 0.927–1.056); sex variable (95% CI: 0.238–2.743, OR = 0.808); BMI variable (95% CI: 0.927–1.056, OR = 0.953); vitamin D variable (95% CI: 0.333–6.769, OR = 1.502); omega3 variable (95% CI: 0.410–7.688, OR = 1.776); calcium variable (95% CI: 0.041–3.738, OR = 0.391); calcium variable (95% CI: 0.041–3.738, OR = 391); multiVIT variable (95% CI: 0.211–5.645, OR = 1.090); VitC variable (95% CI: 0.000–0.000, OR = 0.000); vitE variable (95% CI: 0.000–0.000, OR = 0.000); were the interval includes. There were no statistically significant multivariate associations (P > 0.05) between the explanatory variables infected with COVID-19. There was only a statistically significant correlation between the use of iron tablets and contracting COVID-19 (P = 0.025). Controlling the variables or identifying causal correlations is not feasible due to the observational nature of the study. The results cannot be safely extrapolated to other regions of the world because the cohort sample was limited to inhabitants of Iran.
作者简介
F. Ghorat
Sabzevar University of Medical Sciences
Email: jalambadaniz@gmail.com
Associate Professor of Traditional Medicine, Department of Traditional Medicine, Faculty of Medicine
伊朗伊斯兰共和国, SabzevarA. Ganj Bakhsh
Sabzevar University of Medical Sciences
Email: jalambadaniz@gmail.com
MD Student, Department of Medicine, Faculty of Medicine
俄罗斯联邦, SabzevarR. Ataee
Sabzevar University of Medical Sciences
Email: jalambadaniz@gmail.com
MD Student, Student Research Committee, Faculty of Medicine
伊朗伊斯兰共和国, SabzevarR. Borghabani
Sabzevar University of Medical Sciences
Email: jalambadaniz@gmail.com
Instructor of Epidemiology, Non-Communicable Diseases Research Center
伊朗伊斯兰共和国, SabzevarZ. Jalambadani
Sabzevar University of Medical Sciences
编辑信件的主要联系方式.
Email: jalambadaniz@gmail.com
Assistant Professor of Health Education and Promotion, Department of Community Medicine, Faculty of Medicine; Assistant Professor of Health Education and Promotion, Department of Non-Communicable Diseases Research Center, Faculty of Medicine
伊朗伊斯兰共和国, Sabzevar参考
- Adebamowo S.N., Spiegelman D., Willett W.C., Rexrode K.M. Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses. Am. J. Clin. Nutr., 2015, vol. 101, no. 6, pp. 1269–1277. doi: 10.3945/ajcn.114.100354
- Atherton J.G., Kratzing C.C., Fisher A. The effect of ascorbic acid on infection chick-embryo ciliated tracheal organ cultures by coronavirus. Arch. Virol., 1978, vol. 56, no. 3, pp. 195–199. doi: 10.1007/BF01317848
- Bae M., Kim H. Mini-Review on the Roles of Vitamin C., Vitamin D., and Selenium in the Immune System against COVID-19. Molecules, 2020, vol. 25, no. 22: 5346. doi: 10.3390/molecules25225346
- Cao P., Song Y., Zhuang Z., Ran J., Xu L., Geng Y., Han L., Zhao S., Qin J., He D., Wu F., Yang L. Obesity and COVID-19 in Adult Patients With Diabetes. Diabetes, 2021, vol. 70, no. 5, pp. 1061–1069. doi: 10.2337/db20-0671
- Cao Q., Lei H., Yang M., Wei L., Dong Y., Xu J., Nasser M., Liu M., Zhu P., Xu L., Zhao M. Impact of cardiovascular diseases on COVID-19: a systematic review. Med. Sci. Monit., 2021, vol. 27: e930032. doi: 10.12659/MSM.930032
- Cereda E., Bogliolo L., Klersy C., Lobascio F., Masi S., Crotti S., De Stefano L., Bruno R., Corsico A.G., Di Sabatino A., Perlini S., Montecucco C., Caccialanza R.; NUTRI-COVID19 IRCCS San Matteo Pavia Collaborative Group. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin. Nutr., 2021, vol. 40, no. 4, pp. 2469–2472. doi: 10.1016/j.clnu.2020.10.055
- Chiscano-Camón L., Ruiz-Rodriguez J.C., Ruiz-Sanmartin A., Roca O., Ferrer R. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit. Care, 2020, vol. 24, no. 1: 522. doi: 10.1186/s13054-020-03249-y
- Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A., Jain S.S., Burkhoff D., Kumaraiah D., Rabbani L., Schwartz A., Uriel N. COVID-19 and cardiovascular disease. Circulation, 2020, vol. 141, no. 29, pp. 1648–1655. doi: 10.1161/CIRCULATIONAHA.120.046941
- Dehghani-Samani A., Kamali M., Hoseinzadeh-Chahkandak F. The role of vitamins on the prevention and/or treatment of COVID-19 infection; a systematic review. Mod. Care J., 2020, vol. 17, no. 3, pp. 1–13. doi: 10.5812/modernc.104740
- Farshchi H.R., Madjd A., Malekzadeh R. Overview: Beneficial Effects of Multivitamin Mineral Supplements. Govaresh, 2019, vol. 24, pp. 6–11.
- Groban L., Wang H., Sun X., Ahmad S., Ferrario C.M. Is Sex a Determinant of COVID-19 Infection? Truth or Myth? Curr. Hypertens Rep., 2020, vol. 22, no. 9: 62. doi: 10.1007/s11906-020-01073-x
- Hashim M.J., Alsuwaidi A.R., Khan G. Population Risk Factors for COVID-19 Mortality in 93 Countries. J. Epidemiol. Glob. Health., 2020 , vol. 10, no. 3, pp. 204–208. doi: 10.2991/jegh.k.200721.001
- Hessami A., Shamshirian A., Heydari K., Pourali F., Alizadeh-Navaei R., Moosazadeh M., Abrotan S., Shojaie L., Sedighi S., Shamshirian D., Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am. J. Emerg. Med., 2021, vol. 46, pp. 382–391. doi: 10.1016/j.ajem.2020.10.022
- Kaya M.O., Pamukçu E., Yakar B. The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies. Epidemiol. Health, 2021, vol. 43: e2021074. doi: 10.4178/epih.e2021074
- Kumar P., Kumar M., Bedi O., Gupta M., Kumar S., Jaiswal G., Rahi V., Yedke N.G., Bijalwan A., Sharma S., Jamwal S. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology, 2021, vol. 29, no. 4, pp. 1001–1016. doi: 10.1007/s10787-021-00826-7
- Mohsin F.M., Tonmon T.T., Nahrin R., Tithy S.A., Ame F.A., Ara I., Alam S.K.T., Pervej A.M.A., Shahjalal M., Hawlader M.D.H. Association Between Smoking and COVID-19 Severity: Evidence from Bangladesh. J. Multidiscip. Health, 2021, vol. 23, no. 14, pp. 1923–1933. doi: 10.2147/JMDH.S317603
- Nimer R.M., Khabour O.F., Swedan S.F., Kofahi H.M. The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization. Bosn. J. Basic. Med. Sci., 2022, vol. 22, no. 5, pp. 826–832. doi: 10.17305/bjbms.2021.7009
- Nursyifa Fadiyah N., Megawati G., Erlangga Luftimas D. Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review. Int. J. Gen. Med., 2022, vol. 11, no. 15, pp. 3915–3922. doi: 10.2147/IJGM.S357460
- Samsami M., Mehravaran E., Tabarsi P., Javadi A., Arsang-Jang S., Komaki A., Taheri M., Ghafouri-Fard S. Clinical and demographic characteristics of patients with COVID-19 infection: Statistics from a single hospital in Iran. Hum. Antibodies, 2021, vol. 29, no. 1, pp. 49–54. doi: 10.3233/HAB-200428
- Sattar N., McInnes I.B., McMurray J.J.V. Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation, 2020, vol. 142, no. 1, pp. 4–6. doi: 10.1161/CIRCULATIONAHA.120.047659
- Srivastava K. Association between COVID-19 and cardiovascular disease. IJC Heart & Vasculature, 2020, vol. 29, no. 100: 583 doi: 10.1016/j.ijcha.2020.100583
- Suriawinata E., Mehta K.J. Iron and iron-related proteins in COVID-19. Clin. Exp. Med., 2023, vol. 23, no. 4, pp. 969–991. doi: 10.1007/s10238-022-00851-y
- Tepasse P.R., Vollenberg R., Fobker M., Kabar I., Schmidt H., Meier J.A., Nowacki T., Hüsing-Kabar A. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients, 2021, vol. 13, no. 7: 2173. doi: 10.3390/nu13072173
- Tomasa-Irriguible T.M., Bielsa-Berrocal L. COVID-19: Up to 82% critically ill patients had low Vitamin C values. Nutr. J., 2021, vol. 20, no. 1: 66. doi: 10.1186/s12937-021-00727-z
- Yupari-Azabache I., Bardales-Aguirre L., Rodriguez-Azabache J., Barros-Sevillano J.S., Rodríguez-Diaz A. COVID-19 mortality risk factors in hospitalized patients: a logistic regression model. Revista de la Facultad de Medicina Humana, 2021, vol. 21, pp. 19–27. doi: 10.25176/RFMH.v21i1.3264
- Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020, vol. 395, no. 10299: 1038. doi: 10.1016/S0140-6736(20)30566-3